TR Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Buy TR now for a near-term momentum/swing push. The tape is turning bullish (MACD expanding >0) and price is holding above the pivot (37.498) with a high-probability short-term upside setup (pattern study points to ~+5% next day / ~+6% next week). With no proprietary sell/avoid signals today and options positioning leaning call-heavy, TR looks like an attractive immediate entry for an impatient buyer aiming for a quick move toward 38.05–38.38.
Trend/structure: TR is trading at 37.88 post-market, above the pivot (37.498) and pressing into near-term resistance (R1 38.045, then R2 38.382). Momentum: MACD histogram is +0.0613 and positively expanding, which supports an upside continuation attempt. RSI(6)=64.62 is still in the neutral zone (not overbought), consistent with room for a push higher. Moving averages are converging, which often precedes a breakout-style move; with price above pivot and MACD strengthening, the bias is slightly bullish into R1/R2. Levels: Support S1 36.952 then S2 36.615; resistance 38.045 then 38.382. Quant/pattern read: Similar candlestick-pattern cohort implies ~70% odds of +5.02% next day and +6.01% next week, but slightly negative over the next month (-0.73%), suggesting this is better framed as a short-term trade than a set-and-forget entry.
Technical momentum improving: MACD expanding above zero with price holding above pivot support.
Options skew/flow bullish: call-heavy interest (OI put/call 0.
and zero put volume today.
Event setup: Next earnings (QDec
scheduled for 2026-02-11 after hours can act as a catalyst; elevated IV reflects anticipation.
Recent fundamentals are steadily improving (see latest quarter).
Overhead resistance nearby: 38.045–38.382 is immediate supply; upside may stall there short-term.
Medium-term edge is weaker: pattern study shows slightly negative expectation over the next month (-0.73%), implying momentum may fade after the short-term pop.
No news tailwind this week: there’s no fresh headline catalyst currently driving demand.
Options are relatively expensive vs realized volatility (IV > HV), which can temper risk/reward for new option buyers and suggests the move may already be partly priced.
Latest reported quarter: 2025/Q3. Revenue increased to $232.705M (+3.00% YoY). Net income rose to $35.659M (+8.57% YoY). EPS increased to $0.49 (+8.89% YoY). Gross margin improved to 34.12% (+0.03% YoY). Takeaway: steady, low-to-mid single-digit top-line growth with faster earnings/EPS growth—supportive for a defensive, quality-profile name and consistent with the stock’s constructive technical setup.
No analyst rating/price-target change data was provided, suggesting limited recent Street updates. Wall Street-style pros: consistent profitability, improving EPS, and defensive consumer-staples characteristics. Cons: growth appears modest (revenue +3% YoY) and without fresh catalysts, the stock can trade more on technicals/positioning than on rapid fundamental re-rating. Influential buying/selling: Hedge funds neutral; insiders neutral; no recent Congress trading data available.
